Comparing Prolastin vs Venclexta
| Prolastin (alpha 1-proteinase inhibitor) | Venclexta (venetoclax) |
|
|---|
| Prolastin (alpha 1-proteinase inhibitor) | Venclexta (venetoclax) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Alpha-1 Proteinase Inhibitor Deficiency. Prolastin may also be used for purposes not listed in this medication guide. |
Prescription only
Venclexta is a BCL-2 inhibitor that may be used to treat chronic lymphocytic leukemia (CLL), small cell lymphoma (SCL), or acute myeloid leukemia. It is an oral tablet that is administered once... View more |
||||||||
| More about Prolastin (alpha 1-proteinase inhibitor) | More about Venclexta (venetoclax) | ||||||||
| Ratings & Reviews | |||||||||
|
Be the first to share your experience with this drug. |
Venclexta has an average rating of 8.6 out of 10 from a total of 11 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Prolastin side effects |
View all Venclexta side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Venclexta prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other alpha 1-proteinase inhibitor brands include: Aralast, Aralast NP, Glassia, Prolastin-C, Zemaira |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
120 hours |
26 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 460 drugs are known to interact with Venclexta:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
April 11, 2016 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Prolastin-C
Prolastin-C is used for alpha-1 proteinase inhibitor deficiency
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Zemaira
Zemaira is used to treat alpha 1-antitrypsin deficiency in people who have symptoms of emphysema ...
Aralast NP
Aralast NP is used for alpha-1 proteinase inhibitor deficiency
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.